These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9603013)

  • 21. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of gastrointestinal protein adsorption on the in vitro release of AZT from ethylcellulose microspheres.
    Abu-Izza KA; Lu DR
    Pharm Dev Technol; 1998 Nov; 3(4):495-501. PubMed ID: 9834952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo dapsone release from hydroxyapatite reservoirs.
    Lasserre A; Berty S; Bajpai PK
    Biomed Sci Instrum; 1997; 33():149-54. PubMed ID: 9731351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue.
    Vrouenraets SM; Wit FW; Garcia EF; Huber M; Brinkman K; Moyle G; Domingo P; Tarr PE; Podzamczer D; Ristola M; Gatell JM; Livrozet JM; Furrer H; Reiss P;
    HIV Clin Trials; 2012; 13(2):103-10. PubMed ID: 22510357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.
    N'da DD; Breytenbach JC
    J Pharm Pharmacol; 2009 Jun; 61(6):721-31. PubMed ID: 19505362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection.
    Estrela Rde C; Salvadori MC; Suarez-Kurtz G
    Rapid Commun Mass Spectrom; 2004; 18(10):1147-55. PubMed ID: 15150840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research development of hydroxyapatite-based composites used as hard tissue replacement].
    Ning C; Dai K
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):550-4. PubMed ID: 14565037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations.
    Torres SM; Walker DM; Carter MM; Cook DL; McCash CL; Cordova EM; Olivero OA; Poirier MC; Walker VE
    Environ Mol Mutagen; 2007; 48(3-4):224-38. PubMed ID: 17358033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
    Kerr SG; Anderson KS
    Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral combination treatment prolongs life in people with HIV/AIDS.
    Cooper EC
    AMFAR Rep; 1996 Jan; ():1-5. PubMed ID: 11363617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes.
    Jin SX; Bi DZ; Wang J; Wang YZ; Hu HG; Deng YH
    Pharmazie; 2005 Nov; 60(11):840-3. PubMed ID: 16320946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gel-derived bioglass as a compound of hydroxyapatite composites.
    Cholewa-Kowalska K; Kokoszka J; Laczka M; Niedźwiedzki L; Madej W; Osyczka AM
    Biomed Mater; 2009 Oct; 4(5):055007. PubMed ID: 19779249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
    Meng Q; Su T; O'Neill JP; Walker VE
    Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evidence of baicalein's inhibition of the metabolism of zidovudine (AZT).
    Wang YC; Yang HY; Kong LT; Yu FX
    Afr Health Sci; 2014 Mar; 14(1):173-7. PubMed ID: 26060475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications.
    Kayitare E; Vervaet C; Ntawukulilyayo JD; Seminega B; Bortel V; Remon JP
    Int J Pharm; 2009 Mar; 370(1-2):41-6. PubMed ID: 19059324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evaluation of zidovudine (AZT)-loaded ethylcellulose microspheres after oral administration in beagle dogs.
    Abu-Izza K; Tambrallo L; Lu DR
    J Pharm Sci; 1997 May; 86(5):554-9. PubMed ID: 9145378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyapatite ceramics for continuous delivery of heparin.
    Abrams L; Bajpai PK
    Biomed Sci Instrum; 1994; 30():169-74. PubMed ID: 7948632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.
    Bruisten SM; Reiss P; Loeliger AE; van Swieten P; Schuurman R; Boucher CA; Weverling GJ; Huisman JG
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1053-8. PubMed ID: 9718120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.
    Li T; Guo F; Li Y; Zhang C; Han Y; Lye W; He Y; Lu H; Xie J; Huang A; Li Y; Tang X; Wang H; Zhang T; Gao G; Lei J; Zhang X; Wu X; Sun Y; Bai J; Luo L; Wang H
    Chin Med J (Engl); 2014; 127(1):59-65. PubMed ID: 24384425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.